GeninCode (GENI) looking into New Year25 Nov 2023 10:14
Hi Guys, I know this is effectively a Pharma stock but as it is one of my holdings and I keep an eye on it regularly then I wanted to share my thoughts and any of yours.
Geni applied for FDA Approval on its CardioInCode Score testing in August and results of that application are due early to mid Q1 2024 (Not long now!). There are revenues coming in already from the Lab based tests but this is for the Pack derivative of the test which has increased margins at sale and will allow hundreds of other Clia labs around the USA to perform the test. This has and is being readily adopted by many tier one medical institutions already on a consultants experience programme and should be readily adopted commercially. Management are talking about being breakeven by 2025. Now Geni has a relatively small share float with BOD having good skin in the game and appear to me as some of the most professional I have experienced on AIM.
The BOD have stretched the initial IPO Funding to 3 years and I believe will try and keep things going along nicely until FDA approval but will then need to raise for the big sales push into 2024. There is no suggestion of the size of raise at present but it will mostly be used to directly generate an increase in sales so I don't see it as a negative. The share price makes big gains and losses on small numbers of transactions and went increased 175% one day on Clia lab approval some months back but has subsequently dropped back, I guess to the worries of a raise although on small transaction numbers. I know there is always a concern regards FDA Approvals but the board has been thorough and delayed application by directly approaching any initial concerns by the pre application board and as such my own fears about it are minimal.
Therefore is there a great opportunity at these ridiculously low SP levels to bag some profits over the next few months? Well, obviously any cash raise must be monitored and this may not have to be done with new shares as there where suggestions of other finance routes and even tie ins with Pharma companies, but I still feel a great opportunity exists and the situation as an investor should be monitored closely. I just wanted to give an early heads up to anybody interested to take a further look as there could be a good bounce on news and would appreciate any ideas that you have. Sun is shining so keep smiling and DYOR, Swissy.